Pharmaceutical Gelatin Market by Source (Porcine, Bovine Skin, Bovine Bone, Fish, Poultry), Application (Hard Capsule, Soft Capsule, Tablet, Absorbable Hemostat), Function (Stabilizing, Thickening, Gelling), Region – Global Forecast to 2025

2020-10-02
Price :
Published : Oct-2020
No. of Pages : 194
Inquire before Buying request discount

“The global pharmaceutical gelatin market is projected to grow at a CAGR of 5.3%.”

The global pharmaceutical gelatin market is projected to reach USD 1.2 billion by 2025 from USD 1.0 billion in 2020, at a CAGR of 5.3% during the forecast period. Growth in this market is driven by the advantages of pharmaceutical gelatin such as utility and versatility in medical and biomedical applications, unique functional properties, natural source of origin, and the increasing demand for pharmaceutical applications such as hard capsules and soft gel capsules. However, factors such as cultural restrictions in consumption of porcine or bovine-derived gelatin, and rising prices of raw material are expected to restrain the growth of this market to a certain extent during the forecast period.

“The hard capsules segment holds the highest market share, by application, in the forecast period.”

On the basis of application, the pharmaceutical gelatin market is segmented into hard capsules, soft gel capsules, tablets, absorbable hemostats& other applications. The hard capsules segment is is expected to hold the highest share in the pharmaceutical gelatin market during the forecast period. Growth in this segment is largely driven by the stability, safety, security and efficacy provided by gelatin in hard capsules, and suitability of gelatin hard capsules for immediate-release dosing.

“Increasing preference for bovine bone as an alternative to pig meat gelatin in the pharmaceutical industry driving market growth for this segment.”

On the basis of source, the pharmaceutical gelatin market is further segmented into porcine, bovine skin, bovine bone, marine & poultry. The bovine bone segment is projected to witness the highest growth in the pharmaceutical gelatin market, by source, during the forecast period. Bovine bone is suitable for use across a range of pharmaceutical applications including hard and soft gel capsules, tablets, gelatin sponges, and plasma expanders due to its low Bloom and high viscosity. The high viscosity to Bloom ratio of bovine bone is especially advantageous in the manufacture of soft gel capsules. These factors are accelerating the growth of this segment during the forecast period.

“By function, the stabilizing agent segment holds the highest market share in the pharmaceutical gelatin market”

On the basis of function, the pharmaceutical gelatin market is further segmented into stabilizing agent, thickening agent, gelling agent & other functions. The stabilizing agent segment is expected to hold the highest share in the pharmaceutical gelatin market, by source, during the forecast period.Gelatin has the ability to reduce surface and interfacial tensions, adsorb on to solid surfaces, and enhance the stability of oil-in-water emulsions, moreover, film formation by gelatin can stabilize surface interfaces by forming a film. These effects are utilized in the stabilization of emulsions in pharmaceutical applications and can be attributed to the large market share of this segment during the forecast period.

“By type, Type A pharmaceutical gelatin is growing at the fastest rate in the forecast period”

On the basis of type, the pharmaceutical gelatin market is further segmented into Type A and Type B. The Type A segment relates mainly to porcine gelatin.The Type A process for porcine gelatin requires shorter time for pre-treatment prior to the extraction of gelatin and minimizes the generation of waste water. These factors are projected to drive the growth of the Type A segment during the forecast period.

“North American region holds the highest market share in the pharmaceutical gelatin market”

North America is expected to account for the largest share of the global pharmaceutical gelatin market in 2019. The large share of the North American region is due to the demand for gelatin for applications in the pharmaceutical industry, easy availability of raw material in the region and business presence of a large number of market players in the region.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1–36%, Tier 2–39%, and Tier 3–25%
  • By Designation: C-level–23%, Director Level–36%, and Others–41%
  • By Region: North America–40%, Europe–15%, Asia Pacific–29%, Latin America- 8%, Middle East & Africa – 8%

The prominent players in the global pharmaceutical gelatin market are Darling Ingredients Inc. (US), Nitta Gelatin Inc (Japan), Tessenderlo Group (Belgium), Gelita AG (Germany), Weishardt (France), TrobasGelatine B.V. (Netherlands), LapiGelatine S.p.A (Italy), Italgelatine S.p.A (Italy), Xiamen Gelken Gelatin Co. Ltd. (China), Gelco International (Brazil), Aspire Pharmaceuticals. (US), India Gelatine& Chemicals Ltd. (India), GelnexIndustria E Comercio Ltda (Brazil), JuncaGelatines (Spain), Henan Boom Gelatin Co. Ltd (China), Baotou Dongbao Bio-Tech Co. Ltd (China), Norland Products Inc. (US), Geltech Co.  Ltd (South Korea), Geliko LLC (US), and Kenney & Ross Limited (Canada).

Research Coverage:

The report analyzes the market for various pharmaceutical gelatin market and their adoption pattern. It aims at estimating the market size and future growth potential of the global pharmaceutical gelatin market and different segments such as application, source, type, function and regions. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product& service offerings, and recent developments.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help the magner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global pharmaceutical gelatin market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities,and product or service launches in the global pharmaceutical gelatin market
  • Market Development: Comprehensive information on the lucrative emerging regions by products, end user,and region
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global pharmaceutical gelatin market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis,and products& services of leading players in the global pharmaceutical gelatin market
Filed in: Pharmaceutical
Publisher : marketsandmarkets
More Reports
Title Price Buy Now

Ambulatory EHR Market by Delivery Mode (Cloud-based, On-premise), Application (e-Prescribing, PHM, Health Analytics, Practice, Patient & Referral Management), Practice Size (Large, Small-to-Medium, Solo), End User (Independent) – Global Forecast to 2027

“The ambulatory EHR market is projected to grow at a CAGR of 6.1% between 2022 and 2027.” The global ambulatory EHR market is projected to reach USD 5.7 billion in 2022 to USD 7.7 billion by 2027, at a CAGR of 6.1%during the forecast period. Growth in this market is driven by the opportunities provided by the market such as increasing demand for cloud-based ambulatory EHR market, and shift towards patient-centric healthcare delivery. However, the interoperability issues & data security concerns are some of the challenges that are expected to limit the growth of the market to a certain extent during the forecast period. “Cloud-based was the fastest-growing segment in the delivery mode of ambulatory EHR market in 2021” Cloud-based segment is projected to growth at the hi......
 $4950

Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohydrates), Inorganic Chemicals (Calcium Phosphate)), Functionality (Fillers, Binders, Lubricants, Preservatives), Formulation (Tablets, Capsules, Parenteral) – Global Forecast to 2027

“The pharmaceutical excipients market growth can be attributed to factors such as the rising pharmaceuticals market, advancements in functional excipients, and the growing generics market. The rapidly growing biopharmaceuticals sector will also influence market growth..” The pharmaceutical excipients market is projected to reach USD 11.5 Billion by 2027 from USD 8.6 Billion in 2022, at a CAGR of 5.9% during the forecast period.The growth can be attributed to the expanding pharmaceutical industry which has fueled the drug production thereby increasing consumption rate for excipients. Additionally, factors like functional excipients development and upsurge in generics market is also likely to propel market growth. “The fillers & diluents functionality accounted for the larges......
 $

Digital Pharmacy Market by Drug (Rx, OTC), Product (Medicine, Personal Care, Vitamins & Supplements, Diabetes, CVD, Oncology), Platform (Apps, Websites), Business Model (Captive, Franchise, Aggregator), Geographic (Urban, Rural) – Global Forecasts to 2027

“Digital Pharmacy market to register a CAGR of 17.0%  during the forecasts period The digital pharmacy market is expected to reach USD 211.9 billion by 2027 from USD 96.5 billion in 2022, at a CAGR of 17.0% during the forecast period. The growth of this market is driven by the growing consumer preference toward buying online medicines during and post COVID-19 pandemic, consolidation in the market and partnerships, and increasing geriatric population. However, patients relying on pharmacists for clinical support and increasing number of illegal pharmacies are expected to restrain the growth of this market during the forecast period. “Over-the-counter (OTC) products segment is estimated  to grow at the highest rate during the forecast period” On the basis  ofdrug type, t......
 $4950

Pharmacy Automation Market by Product (Automated Medication Dispensing & Storage Systems, Table-Top Counters, Retrieval Systems, Medication Compounding), End User (Inpatient, Outpatient (Fast-Track Clinics), Retail Pharmacies) – Global Forecast to 2027

The pharmacy automation market is expected to grow at a CAGR of 7.9% in the forecast period. The pharmacy automation market is projected to reach USD 8.2 billion by 2027 from USD 5.6 billion in 2022, at a CAGR of 7.9% during the forecast period. The growth in this market is attributed to the growing need to minimize medication errors, rapid decentralization of pharmacies, and growing focus on automation to reduce labor costs. However, the stringent regulations that delay product launches can inhibit the growth of this market. Based on product, the automated medication dispensing and storage systems segment holds the largest market share in 2021 Based on products, the pharmacy automation market is segmented into automated medication dispensing and storage systems, automated packagi......
 $4950

Topical Drug Delivery Market by Type (Semi-solids (Creams, Gels, Lotions), Solids(Suppositories), Liquids(Solutions), Transdermal products), Route(Dermal, Ophthalmic), Facility of Use (Homecare setting, Hospitals, Burn Centres) – Global Forecast to 2027

The topical drug delivery market is expected to grow at a CAGR of 8.9% in the forecast period. The global topical drug delivery market is projected to reach USD 317.8 billion by 2027 from USD 207.4 billion in 2022, at a CAGR of 8.9%. The growth of this market can largely be attributed to the high prevalence of topical prescription therapy for dry eye diseases,  growing focus of pharmaceutical companies on the R&D of smart transdermal drug delivery systems, increase in prevalence of central nervous disorders,  rising preference for non-invasive drug delivery methods. “The semi-solid formulation segment accounted for the largest share of the topical drug delivery market, based on  product in 2021.” Based on products, the topical drug delivery the market is segmented into ......
 $4950

Cognition and Memory Enhancement Market by Product & Service (Cognition & Memory-enhancing Drugs, Brain-boosting Nutraceuticals, Cognitive Assessment & Training Solutions), Region (North America, Europe, Asia Pacific, ROW) – Global Forecast to 2026

“Increasing incidence and prevalence of neurological disorders is a key factors driving growth in the cognition and memory enhancement market’’ The global cognition and memory enhancement market is projected to reach USD 38.9 billion by 2026 from USD 23.4 billion in 2021, at a CAGR of 10.7% during the forecast period. Elevating prevalence of neurological disorders, such as dementia, epilepsy, Parkinson’s disease, Huntington’s disease, headache disorders, multiple sclerosis, neuroinfections, stroke, and cerebral palsy, have increased significantly over the years. “By product & service segment, the cognition & memory-enhancing drugs segment has registered fastest growth rate during the forecast period” Based on product & service, the cognition and memory en......
 $4950

High Potency APIs/HPAPI Market by Type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), Manufacturers (Captive, Merchant), Application (Oncology, Hormonal Imbalance, Glaucoma) Region – Global forecast to 2027

The HPAPI market is projected to reach USD 39.6 Billion by 2027 from USD 24.5 billion in 2022, at a CAGR of 10.1% from 2022 to 2027. The market is driven by increasing demand for oncology drugs, growing demand for antibody-drug conjugates and others. “The innovative HPAPIs segment is expected to account for the largest share of the market in 2021” Based on type, the HPAPI market is segmented into innovative and generic. The innovative segment is expected to account for the largest share of the HPAPI market in 2021. The large share can be attributed to the increased R&D investments. “The Synthetic APIs segment to account for the largest share of the market in 2021” Based on type of synthesis, the market is segmented into synthetic and biotech HPAPIs. The synthetic AP......
 $4950

Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) – Global Forecast to 2027

“Increased risk of communicable diseases, Rising prevalence of bleeding disorders in global population, Use of Immunoglobulin’s for a range of neurological conditions, including multiple sclerosis, neuropathic pain, and chronic fatigue syndrome is expected to drive the overall growth of the plasma fractionation market.” The global plasma fractionation market size is projected to reach USD 36.7 billion by 2027 from USD 26.5 billion in 2022, at a CAGR of 6.7% during the forecast period. Market growth is driven mainly by factors such as rapid growth of geriatric population, growing prevalence of respiratory disorders such as alpha-1-antitrypsin deficiency (AATD) and emphysema, and use of plasma fractionation products as first-line therapies for a number of bleeding, hematological, an......
 $4950

Patient Engagement Solutions Market by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) – Global Forecast to 2027

“Patient engagement solutions market to register a CAGR of 10.0% from 2022 to 2027” The patient engagement solutions market is projected to reach USD 27.9 billion by 2027 from USD 17.3 billion in 2022, at a CAGR of 10.0% during the forecast period. The growth of this market is driven by the adoption and changes in government regulations to promote patient-centric care and involve patients throughout the care journey, high demand for patient engagement solutions, and the growing utilization of m- health apps. However, interoperability issues for patient engagement solutions and a dreadth of skilled IT professionals in the healthcare industry are expected to restrain the growth of this market during the forecast period. “Services segment is expected to grow at the highest rate......
 $4950

Healthcare Cloud Computing Market by Product (EMR/EHR, VNA, RIS, LIS, PIS), Deployment (Private Cloud, Hybrid Cloud, Public Cloud), Component (Software, Services), Pricing (Spot Pricing), Service (SaaS, IaaS, PaaS), End User – Global Forecasts to 2027

The global Healthcare cloud computing market is projected to reach USD 89.4  billion by 2027 from USD 39.4 billion in 2022, at a CAGR of 17.8%. The factors driving the market are adoption of technologies like telehealth, EHR, big data analytics, IoT, cloud computing, m health, wearlable devices, etc. “The healthcare provider solution was the largest segment in the healthcare cloud computing market in 2021.” The healthcare provider segment accounted for the larger share of 79.2% of the healthcare cloud computing market in 2021. The growing adoption of various health IT solutions such as EHR, e-prescribing, telehealth, mHealth, and others due to COVID-19 is one of the key factors contributing to the growth of this segment. “Among end users, the healthcare providers segment ac......
 $4950
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy